Clinical pharmacology profile of the claudin 18.2 antibody zolbetuximab.

Authors

null

Jianning Yang

Astellas Pharma Global Development, Inc., Northbrook, IL

Jianning Yang , Akihiro Yamada , Samuel J. Klempner , Sara Lonardi , Kohei Shitara , Rui-Hua Xu , David H. Ilson , Yoko Ueno , Masato Takeuchi , Janet Pavese , Tomasz Wojtkowski , Maria Matsangou , Srinivasu Poondru

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT00909025NCT01671774NCT03528629NCT04086758NCT01197885NCT01630083NCT03505320NCT03504397NCT03653507

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 316)

DOI

10.1200/JCO.2024.42.3_suppl.316

Abstract #

316

Poster Bd #

E16

Abstract Disclosures

Similar Posters